posted on Sep 01 by MedPage Today OB/Gyn in the Uncategorized category
(MedPage Today) -- Patients with bulky, advanced ovarian cancer survived just as long whether treated with neoadjuvant chemotherapy and surgery or with primary surgery followed by adjuvant chemotherapy, investigators in a multinational trial reported.